Approaching personalized cancer medicine

被引：0
作者：
G. Gastl
机构：
[1] Medical University of Innsbruck,Department of Haematology and Oncology
来源：
memo - Magazine of European Medical Oncology | 2008年 / 1卷 / 3期
关键词：
Personalized cancer; Biobanking; Biomakers; Predictive test;
D O I：
10.1007/s12254-008-0046-x
中图分类号：
学科分类号：
摘要：
In general, the translation of advances in biomedical research into innovative and personalized approaches for cancer treatment is rising on the agenda of translational and clinical cancer research, biomedical industries and healthcare systems around the world. Cancer therapies are changing, gradually moving away from the administration of cytotoxic drugs towards specific therapies that are targeted to each tumour. To facilitate this shift, molecular tests need to be developed to identify those patients at risk who require therapy and those who most likely benefit from certain therapies.
引用
收藏
页码：121 / 123
页数：2
相关论文
共 13 条
  • [1] Rhodes DR(2007)Molecular concepts analysis links tumors, pathways, mechanisms, and drugs Neoplasia 9 443-454
  • [2] Park JW(2004)Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development Clin Cancer Res 10 3885-3896
  • [3] Trusheim MR(2007)Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers Nature Rev Drug Discovery 6 287-293
  • [4] Compton C(2007)Geeting to personalized cancer medicine. Taking out the garbage Cancer 110 1641-1643
  • [5] van't Veer LJ(2002)Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530-536
  • [6] Paik S(2004)A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817-2826
  • [7] Wang Y(2005)Gene expression profiles to predict distant metastases of lymph node-negative primary breast cancer Lancet 365 671-679
  • [8] Ma KJ(2006)The HOXB13:IL17BR expression index as a prognostic factor in early stage breast cancer J Clin Oncol 24 4611-4619
  • [9] van de Vijver M(2002)A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999-2009
  • [10] Desmedt C(2007)Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Clin Cancer Res 13 3207-3214
12